Nanwei Tong
Overview
Explore the profile of Nanwei Tong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
2250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai X, Yang W, Feng B, Ji Q, Liu M, Li Y, et al.
Adv Ther
. 2025 Feb;
42(3):1600-1609.
PMID: 39928243
Introduction: This article describes the study rationale and design of the real-world multicenter registry study iCaReMe China. Methods: iCaReMe China is a prospective, multicentric, observational registry study aiming to understand...
2.
Miao Y, Wang Y, Wan Q, Tong N
BMC Cardiovasc Disord
. 2025 Jan;
25(1):35.
PMID: 39833683
Background: The medical community has long been concerned about the cardiovascular disease risk in patients with type 2 diabetes. While liver fibrosis scores were originally designed for application in individuals...
3.
Zhang X, Lu X, Pan X, Shen S, Tong N
Zhong Nan Da Xue Xue Bao Yi Xue Ban
. 2025 Jan;
49(7):1062-1072.
PMID: 39788494
Although body mass index (BMI) is widely used as a simple tool to assess obesity, it has certain limitations and inaccuracies. It is known that visceral adipose tissue is closely...
4.
Miao Y, Wang Y, Yan P, Li Y, Chen Z, Tong N, et al.
Front Endocrinol (Lausanne)
. 2025 Jan;
15:1367853.
PMID: 39758343
Background: The debate persists regarding whether metabolic dysfunction-associated steatotic liver disease (MASLD) actively contributes to coronary heart disease or merely acts as a passive indicator. Objective: This research aims to...
5.
Peng G, Pan X, Ye Z, Yi X, Xie Q, Zhang X, et al.
Endocrine
. 2025 Jan;
PMID: 39745600
Background: The incidence of thyroid cancer has increased annually, but the risk factors for thyroid cancer are still unclear. In this umbrella review, we aimed to identify associations between nongenetic...
6.
Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al.
Signal Transduct Target Ther
. 2024 Oct;
9(1):262.
PMID: 39353925
Type 2 diabetes (T2D) is a disease characterized by heterogeneously progressive loss of islet β cell insulin secretion usually occurring after the presence of insulin resistance (IR) and it is...
7.
Xu S, Xian H, Liao Y, Zhang H, Xia L, Liu Y, et al.
Chin Med J (Engl)
. 2024 Sep;
137(19):2392-2394.
PMID: 39238087
No abstract available.
8.
Liu J, Li J, Xia C, He W, Li X, Wang Y, et al.
Quant Imaging Med Surg
. 2024 Jul;
14(7):5040-5056.
PMID: 39022235
Background: Obesity is commonly linked with heart failure (HF) with preserved ejection fraction, with diastolic dysfunction playing an important role in this type of HF. However, diastolic function has not...
9.
Tao S, Guo S, Tong N
Pharmacotherapy
. 2024 Jul;
44(8):642-657.
PMID: 38973479
Sodium glucose cotransporter inhibitor (SGLTi) drugs have been widely used in clinical practice. In addition to their benefits in hyperglycemia, heart failure (HF), and kidney disease, their effects on obesity,...
10.
Zhang R, Xie Q, Lu X, Fan R, Tong N
Diabetol Metab Syndr
. 2024 May;
16(1):99.
PMID: 38735956
Diabetes mellitus is one of the most significant global burden diseases. It is well established that a chronic, systemic, low-grade inflammatory condition is strongly correlated with type 2 diabetes mellitus...